TY - JOUR
T1 - Traqueoesophageal fistula patients fed through percutaneous endoscopic gastrostomy/gastrojejunostomy
T2 - Nutritional status and clinical outcome
AU - Santos, Carla Adriana
AU - Pereira, Marta
AU - Martins, Vera Santos
AU - Fonseca, Jorge
N1 - Publisher Copyright:
© 2015, Grupo Aula Medica S.A. All rights reserved.
PY - 2015/8/4
Y1 - 2015/8/4
N2 - Background: tracheoesophageal fistula (TEF) may result from cancer or mechanical ventilation. Endoscopic Gastrostomy or Gastrojejunostomy (PEG/PEG-J) is used for nutritional support. Objective: in TEF-patients, evaluating nutritional status when PEG is performed, safety of PEG/PEG-J and clinical outcome. Methods: from the files of PEG/PEG-J feed TEF-patients we collected: clinical data, Body Mass Index, albumin, transferrin and cholesterol when gastrostomy was performed, and clinical outcome globally and according with the TEF cause: Group 1: complication of mechanical ventilation, Group 2: cancer. Results: twelve patients, 18-91 years (median: 53), 11 PEG, one PEG-J: six complications of ventilation (neurological diseases), 6 cancers. Mean period from TEF diagnosis until gastrostomy: 2 months in Group 1, 10 months in Group 2. In the day of the gastrostomy, patients presented with malnutrition parameters, most strikingly in the cancer group. Group 1: died a single patient, 3 closed the TEF, resuming oral intake, 2 are still PEG-feed. All cancer patients died (7 months after gastrostomy). One needed a jejunal extension to create a PEG-J. No more complications. Conclusion: PEG/PEG-J was safe in TEF-patients, but cancer patients underwent gastrostomy too late. In TEF-patients, PEG/PEG-J should be considered in a regular basis, earlier in the disease evolution, before established malnutrition.
AB - Background: tracheoesophageal fistula (TEF) may result from cancer or mechanical ventilation. Endoscopic Gastrostomy or Gastrojejunostomy (PEG/PEG-J) is used for nutritional support. Objective: in TEF-patients, evaluating nutritional status when PEG is performed, safety of PEG/PEG-J and clinical outcome. Methods: from the files of PEG/PEG-J feed TEF-patients we collected: clinical data, Body Mass Index, albumin, transferrin and cholesterol when gastrostomy was performed, and clinical outcome globally and according with the TEF cause: Group 1: complication of mechanical ventilation, Group 2: cancer. Results: twelve patients, 18-91 years (median: 53), 11 PEG, one PEG-J: six complications of ventilation (neurological diseases), 6 cancers. Mean period from TEF diagnosis until gastrostomy: 2 months in Group 1, 10 months in Group 2. In the day of the gastrostomy, patients presented with malnutrition parameters, most strikingly in the cancer group. Group 1: died a single patient, 3 closed the TEF, resuming oral intake, 2 are still PEG-feed. All cancer patients died (7 months after gastrostomy). One needed a jejunal extension to create a PEG-J. No more complications. Conclusion: PEG/PEG-J was safe in TEF-patients, but cancer patients underwent gastrostomy too late. In TEF-patients, PEG/PEG-J should be considered in a regular basis, earlier in the disease evolution, before established malnutrition.
KW - Gastrojejunostomy
KW - Gastrostomy
KW - Nutrition
KW - PEG
KW - Tracheoesophageal fistula
UR - http://www.scopus.com/inward/record.url?scp=84938506472&partnerID=8YFLogxK
U2 - 10.3305/nh.2015.32.2.9078
DO - 10.3305/nh.2015.32.2.9078
M3 - Article
C2 - 26268100
AN - SCOPUS:84938506472
SN - 0212-1611
VL - 32
SP - 691
EP - 695
JO - Nutricion Hospitalaria
JF - Nutricion Hospitalaria
IS - 2
ER -